A better knowledge of the mechanisms of resistance of leishmanias to drugs, of their survival strategy and the investigation of the immune mechanisms developed by the host against these parasites would be of the highest importance in the therapeutic approach of the disease, for a better use of available drugs, to try to stop the infectious process and to develop and immunotherapy and an efficient protection against the disease.